| Company Name: | Bare Escentuals, Incorporated | | Ticker Symbol: | BARE | | | WWW Address: | www.bareescentuals.com | | CEO: | Leslie A. Blodgett | | No. of Employees: | 1,045 | | Common Issue Type: | CS | | Business Description: | The Company together with its subsidiaries develops, markets, and sells cosmetics, skin care and body care products under the bareMinerals, RareMinerals, Buxom and md formulations brands.
|
| | | Industry Information: | CONSUMER NON-DURABLES - Personal Products [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 13.27 |  -0.13 | 13.27 | 13.9 | 13.41 | 13.48 | 13.13 | 684076 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 1,220.8 | 92.0 | 2.93 | 1.05 | 0.00 | 14.9 | 0.0 | 14.87 - 2.45 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 13.27 | $ | | PE Ratio - LTM | 14.9 | |
| Market Capitalisation | 1,221.1 | mil |
| Latest Shares Outstanding | 92.0 | mil |
| Earnings pS (EPS) | 1.05 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 532,215 | $ |
| Effective Tax Rate | 38.6 | % |
| Float | 85.6 | mil |
| Float as % of Shares Outstanding | 93.0 | % |
| Foreign Sales | 66 | mil |
| Domestic Sales | 490 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 41.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 72.7 | % |
| EBITDA Margin | 30.8 | % |
| Pre-Tax Profit Margin | 25.6 | % |
| Assets Turnover | 1.8 | % |
| Return on Assets (ROA) | 25.5 | % |
| Return on Equity (ROE) | 202.6 | % |
| Return on Capital Invested (ROCI) | 32.5 | % |
| Current Ratio | 4.4 | |
| Leverage Ratio (Assets/Equity) | 7.9 | |
| Interest Cover | 11.3 | |
| Total Debt/Equity (Gearing Ratio) | 5.65 | |
| LT Debt/Total Capital | 84.0 | % |
| Working Capital pS | 1.89 | $ |
| Cash pS | 1.06 | $ |
| Book-Value pS | 0.45 | $ |
| Tangible Book-Value pS | 0.22 | $ |
| Cash Flow pS | 1.07 | $ |
| Free Cash Flow pS | 0.86 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 29.47 | |
| Price/Tangible Book Ratio | 59.36 | |
| Price/Cash Flow | 12.4 | |
| Price/Free Cash Flow | 15.4 | |
| P/E as % of Industry Group | 44.0 | % |
| P/E as % of Sector Segment | 83.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -1.8 | 96 | 7,466 | 14,562 |
| 4 Weeks | 14.87 | 12.32 | 12.63 | 5.1 | 98 | 8,179 | 147,224 |
| 13 Weeks | 14.87 | 8.83 | 9.56 | 38.8 | 129 | 8,745 | 542,191 |
| 26 Weeks | 14.87 | 7.25 | 8.75 | 51.7 | 126 | 9,703 | 1,222,620 |
| 52 Weeks | 14.87 | 2.45 | 4.72 | 181.1 | 227 | 8,461 | 2,115,166 |
| YTD | 14.87 | 2.45 | - | 153.7 | 206 | 8,730 | 1,990,365 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 13.46 | 13.84 | 12.81 | 10.19 | 8.64 | 2.93 | 2.93 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 33.15 | 86.5 | 12.14 |
| Income | 0.00 | 0.0 | 8.28 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 83.14 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 13.41 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -4.1 | 4.2 | 8.8 |
| Earnings % | -19.5 | -1.1 | 11.2 |
| EPS % | -20.3 | -4.0 | 10.5 |
| EPS $ | -0.16 | -0.01 | 0.10 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 48.74 |
| Current Ratio | 3.6 |
| Quick Ratio (Acid Test) | 1.6 |
| Liquidity Ratio (Cash) | 0.84 |
| Receivables Turnover | 13.0 |
| Average Collection Period | 28 |
| Working Capital/Equity | -47436.4 |
| Working Capital pS | 1.59 |
| Cash-Flow pS | 1.20 |
| Free Cash-Flow pS | 0.38 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 7.32 |
| Financial Leverage Ratio (Assets/Equity) | 0.0 |
| Debt Ratio | 100.1 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 108.7 |
| LT Debt/Total Liabilities | 74.6 |
| Interest Cover | 10.6 |
| Interest/Capital Invested | 6.81 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 13.78 |
| Tobin's Q Ratio | 4.07 |
| Current P/E Ratio - LTM | 14.90 |
| Enterprise Value (EV)/EBITDA | 7.86 |
| Enterprise Value (EV)/Free Cash Flow | 49.96 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 59.36 |
| Price/Book Ratio - LTM | 29.47 |
| Price/Cash Flow Ratio | 12.4 |
| Price/Free Cash Flow Ratio - LTM | 15.4 |
| Price/Sales Ratio | 2.26 |
| P/E Ratio (1 month ago) - LTM | 14.4 |
| P/E Ratio (26 weeks ago) - LTM | 9.2 |
| P/E Ratio (52 weeks ago) - LTM | 4.4 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 44.0 |
| P/E as % of Sector Segment | 83.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 14.7 |
| PER SHARE FIGURES |
| LT Debt pS | 2.44 |
| Current Liabilities pS | 0.62 |
| Tangible Book Value pS - LTM | 0.22 |
| Book Value pS - LTM | 0.45 |
| Capital Invested pS | 2.43 |
| Cash pS - LTM | 1.06 |
| Cash Flow pS - LTM | 1.07 |
| Free Cash Flow pS - LTM | 0.86 |
| Earnings pS (EPS) | 1.05 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 6.22 |
| Free Cash Flow Margin 5YEAR AVG | -32.74 |
| Net Profit Margin | 17.6 |
| Net Profit Margin - 5YEAR AVRG. | 14.2 |
| Equity Productivity | -1,805.73 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 2.49 |
| Return on Capital Invested (ROCI) | 43.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 48.8 |
| Assets Productivity | 2.10 |
| Return on Assets (ROA) | 32.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | 31.5 |
| Gross Profit Margin | 72.7 |
| Gross Profit Margin - 5YEAR AVRG. | 71.7 |
| EBITDA Margin - LTM | 30.8 |
| EBIT Margin - LTM | 28.1 |
| Pre-Tax Profit Margin | 28.7 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 23.7 |
| Effective Tax Rate | 38.6 |
| Effective Tax Rate - 5YEAR AVRG. | 44.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 204 |
| Revenue per Employee | 532,215 |
| Net Income per Employee | 93,743 |
| Average Collection Period | 27 |
| Receivables Turnover | 13.0 |
| Day's Inventory Turnover Ratio | 177 |
| Inventory Turnover | 2.0 |
| Inventory/Sales | 16.6 |
| Accounts Payble/Sales | 2.97 |
| Assets/Revenue | 0.48 |
| Net Working Capital Turnover | 3.81 |
| Fixed Assets Turnover | 5.76 |
| Total Assets Turnover | 2.1 |
| Revenue per $ Cash | 11.59 |
| Revenue per $ Plant | 7.82 |
| Revenue per $ Common Equity | -1805.73 |
| Revenue per $ Capital Invested | 2.49 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 38.5 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 39.2 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
| | |  |  | |
| |